APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurotoxin-based Injectable Anti-aging Product

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neurotoxin-based Injectable Anti-aging Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchNeurotoxin-based Injectable Anti-aging Product Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotoxin-based Injectable Anti-aging Product Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Neurotoxin-based Injectable Anti-aging Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotoxin-based Injectable Anti-aging Product Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotoxin-based Injectable Anti-aging Product Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Neurotoxin-based Injectable Anti-aging Product market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neurotoxin-based Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurotoxin-based Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurotoxin-based Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neurotoxin-based Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurotoxin-based Injectable Anti-aging Product include LIBP, AbbVie, US World Meds, Revance, Merz Pharmaceuticals, Medytox, Ipsen, Hugel and Galderma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurotoxin-based Injectable Anti-aging Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurotoxin-based Injectable Anti-aging Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurotoxin-based Injectable Anti-aging Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurotoxin-based Injectable Anti-aging Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurotoxin-based Injectable Anti-aging Product Segment by Company

LIBP

AbbVie

US World Meds

Revance

Merz Pharmaceuticals

Medytox

Ipsen

Hugel

Galderma

Daewoong

Neurotoxin-based Injectable Anti-aging Product Segment by Type

A Type Toxin

B Type Toxin

Neurotoxin-based Injectable Anti-aging Product Segment by Application

Hospital

Beauty Salon

Neurotoxin-based Injectable Anti-aging Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotoxin-based Injectable Anti-aging Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotoxin-based Injectable Anti-aging Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotoxin-based Injectable Anti-aging Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurotoxin-based Injectable Anti-aging Product market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurotoxin-based Injectable Anti-aging Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurotoxin-based Injectable Anti-aging Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurotoxin-based Injectable Anti-aging Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurotoxin-based Injectable Anti-aging Product Industry Trends Table 2. Neurotoxin-based Injectable Anti-aging Product Industry Drivers Table 3. Neurotoxin-based Injectable Anti-aging Product Industry Opportunities and Challenges Table 4. Neurotoxin-based Injectable Anti-aging Product Industry Restraints Table 5. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurotoxin-based Injectable Anti-aging Product Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Manufacturers Table 9. Global Neurotoxin-based Injectable Anti-aging Product Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Neurotoxin-based Injectable Anti-aging Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurotoxin-based Injectable Anti-aging Product Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurotoxin-based Injectable Anti-aging Product Manufacturers, Product Type & Application Table 13. Global Neurotoxin-based Injectable Anti-aging Product Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurotoxin-based Injectable Anti-aging Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of A Type Toxin Table 17. Major Manufacturers of B Type Toxin Table 18. Global Neurotoxin-based Injectable Anti-aging Product Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Neurotoxin-based Injectable Anti-aging Product Sales by Type (2021-2026) & (k units) Table 20. Global Neurotoxin-based Injectable Anti-aging Product Sales by Type (2027-2032) & (k units) Table 21. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Type (2021-2026) Table 22. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Type (2027-2032) Table 23. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type (2021-2026) & (k units) Table 25. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type (2027-2032) & (k units) Table 26. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Type (2021-2026) Table 27. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Beauty Salon Table 30. Global Neurotoxin-based Injectable Anti-aging Product Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Neurotoxin-based Injectable Anti-aging Product Sales by Application (2021-2026) & (k units) Table 32. Global Neurotoxin-based Injectable Anti-aging Product Sales by Application (2027-2032) & (k units) Table 33. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Application (2021-2026) Table 34. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Application (2027-2032) Table 35. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application (2021-2026) & (k units) Table 37. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application (2027-2032) & (k units) Table 38. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Application (2021-2026) Table 39. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Application (2027-2032) Table 40. Global Neurotoxin-based Injectable Anti-aging Product Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Neurotoxin-based Injectable Anti-aging Product Sales by Region (2021-2026) & (k units) Table 42. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Region (2021-2026) Table 43. Global Neurotoxin-based Injectable Anti-aging Product Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Neurotoxin-based Injectable Anti-aging Product Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2026) & (k units) Table 47. North America Neurotoxin-based Injectable Anti-aging Product Sales by Country (2027-2032) & (k units) Table 48. Europe Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2026) & (k units) Table 50. Europe Neurotoxin-based Injectable Anti-aging Product Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales by Country (2027-2032) & (k units) Table 57. Global Neurotoxin-based Injectable Anti-aging Product Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Region (2021-2026) Table 61. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Region (2027-2032) Table 62. LIBP Company Information Table 63. LIBP Business Overview Table 64. LIBP Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. LIBP Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 66. LIBP Recent Development Table 67. AbbVie Company Information Table 68. AbbVie Business Overview Table 69. AbbVie Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. AbbVie Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 71. AbbVie Recent Development Table 72. US World Meds Company Information Table 73. US World Meds Business Overview Table 74. US World Meds Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. US World Meds Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 76. US World Meds Recent Development Table 77. Revance Company Information Table 78. Revance Business Overview Table 79. Revance Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Revance Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 81. Revance Recent Development Table 82. Merz Pharmaceuticals Company Information Table 83. Merz Pharmaceuticals Business Overview Table 84. Merz Pharmaceuticals Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merz Pharmaceuticals Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 86. Merz Pharmaceuticals Recent Development Table 87. Medytox Company Information Table 88. Medytox Business Overview Table 89. Medytox Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Medytox Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 91. Medytox Recent Development Table 92. Ipsen Company Information Table 93. Ipsen Business Overview Table 94. Ipsen Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Ipsen Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 96. Ipsen Recent Development Table 97. Hugel Company Information Table 98. Hugel Business Overview Table 99. Hugel Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Hugel Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 101. Hugel Recent Development Table 102. Galderma Company Information Table 103. Galderma Business Overview Table 104. Galderma Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Galderma Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 106. Galderma Recent Development Table 107. Daewoong Company Information Table 108. Daewoong Business Overview Table 109. Daewoong Neurotoxin-based Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Daewoong Neurotoxin-based Injectable Anti-aging Product Product Portfolio Table 111. Daewoong Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Neurotoxin-based Injectable Anti-aging Product Distributors List Table 115. Neurotoxin-based Injectable Anti-aging Product Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Neurotoxin-based Injectable Anti-aging Product Product Image Figure 2. Global Neurotoxin-based Injectable Anti-aging Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotoxin-based Injectable Anti-aging Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurotoxin-based Injectable Anti-aging Product Sales (2021-2032) & (k units) Figure 5. Global Neurotoxin-based Injectable Anti-aging Product Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurotoxin-based Injectable Anti-aging Product Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. A Type Toxin Image Figure 9. B Type Toxin Image Figure 10. Global Neurotoxin-based Injectable Anti-aging Product Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Type (2021-2032) Figure 13. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Beauty Salon Image Figure 18. Global Neurotoxin-based Injectable Anti-aging Product Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Application (2021-2032) Figure 21. Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Application (2021-2032) Figure 24. North America Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Country (2021-2032) Figure 26. U.S. Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Country (2021-2032) Figure 31. Germany Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Country (2021-2032) Figure 38. China Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Country (2021-2032) Figure 46. Brazil Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Neurotoxin-based Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Neurotoxin-based Injectable Anti-aging Product Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million) Figure 57. North America Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million) Figure 59. Europe Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Neurotoxin-based Injectable Anti-aging Product Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Neurotoxin-based Injectable Anti-aging Product Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • A Type Toxin
  • B Type Toxin
Applications
  • Hospital
  • Beauty Salon
Companies covered
  • LIBP
  • AbbVie
  • US World Meds
  • Revance
  • Merz Pharmaceuticals
  • Medytox
  • Ipsen
  • Hugel
  • Galderma
  • Daewoong

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurotoxin-based Injectable Anti-aging Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurotoxin-based Injectable Anti-aging Product Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurotoxin-based Injectable Anti-aging Product Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurotoxin-based Injectable Anti-aging Product Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurotoxin-based Injectable Anti-aging Product Market Dynamics
  1. 2.1 Neurotoxin-based Injectable Anti-aging Product Industry Trends
  2. 2.2 Neurotoxin-based Injectable Anti-aging Product Industry Drivers
  3. 2.3 Neurotoxin-based Injectable Anti-aging Product Industry Opportunities and Challenges
  4. 2.4 Neurotoxin-based Injectable Anti-aging Product Industry Restraints
3 Neurotoxin-based Injectable Anti-aging Product Market by Manufacturers
  1. 3.1 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurotoxin-based Injectable Anti-aging Product Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurotoxin-based Injectable Anti-aging Product Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurotoxin-based Injectable Anti-aging Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurotoxin-based Injectable Anti-aging Product Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurotoxin-based Injectable Anti-aging Product Manufacturers, Product Type & Application
  7. 3.7 Global Neurotoxin-based Injectable Anti-aging Product Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurotoxin-based Injectable Anti-aging Product Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurotoxin-based Injectable Anti-aging Product Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurotoxin-based Injectable Anti-aging Product Tier 1, Tier 2, and Tier 3
4 Neurotoxin-based Injectable Anti-aging Product Market by Type
  1. 4.1 Neurotoxin-based Injectable Anti-aging Product Type Introduction
  2. 4.1.1 A Type Toxin
  3. 4.1.2 B Type Toxin
  4. 4.2 Global Neurotoxin-based Injectable Anti-aging Product Sales by Type
  5. 4.2.1 Global Neurotoxin-based Injectable Anti-aging Product Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Neurotoxin-based Injectable Anti-aging Product Sales by Type (2021-2032)
  7. 4.2.3 Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Type (2021-2032)
  8. 4.3 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type
  9. 4.3.1 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Type (2021-2032)
  11. 4.3.3 Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Type (2021-2032)
5 Neurotoxin-based Injectable Anti-aging Product Market by Application
  1. 5.1 Neurotoxin-based Injectable Anti-aging Product Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Beauty Salon
  4. 5.2 Global Neurotoxin-based Injectable Anti-aging Product Sales by Application
  5. 5.2.1 Global Neurotoxin-based Injectable Anti-aging Product Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Neurotoxin-based Injectable Anti-aging Product Sales by Application (2021-2032)
  7. 5.2.3 Global Neurotoxin-based Injectable Anti-aging Product Sales Market Share by Application (2021-2032)
  8. 5.3 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application
  9. 5.3.1 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Application (2021-2032)
  11. 5.3.3 Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Application (2021-2032)
6 Global Neurotoxin-based Injectable Anti-aging Product Sales by Region
  1. 6.1 Global Neurotoxin-based Injectable Anti-aging Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurotoxin-based Injectable Anti-aging Product Sales by Region (2021-2032)
  3. 6.2.1 Global Neurotoxin-based Injectable Anti-aging Product Sales by Region (2021-2026)
  4. 6.2.2 Global Neurotoxin-based Injectable Anti-aging Product Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region
  1. 7.1 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region
  2. 7.1.1 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurotoxin-based Injectable Anti-aging Product Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurotoxin-based Injectable Anti-aging Product Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032)
  8. 7.2.2 North America Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032)
  11. 7.3.2 Europe Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurotoxin-based Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 LIBP
  2. 8.1.1 LIBP Company Information
  3. 8.1.2 LIBP Business Overview
  4. 8.1.3 LIBP Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 LIBP Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  6. 8.1.5 LIBP Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 US World Meds
  14. 8.3.1 US World Meds Company Information
  15. 8.3.2 US World Meds Business Overview
  16. 8.3.3 US World Meds Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 US World Meds Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  18. 8.3.5 US World Meds Recent Developments
  19. 8.4 Revance
  20. 8.4.1 Revance Company Information
  21. 8.4.2 Revance Business Overview
  22. 8.4.3 Revance Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Revance Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  24. 8.4.5 Revance Recent Developments
  25. 8.5 Merz Pharmaceuticals
  26. 8.5.1 Merz Pharmaceuticals Company Information
  27. 8.5.2 Merz Pharmaceuticals Business Overview
  28. 8.5.3 Merz Pharmaceuticals Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merz Pharmaceuticals Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  30. 8.5.5 Merz Pharmaceuticals Recent Developments
  31. 8.6 Medytox
  32. 8.6.1 Medytox Company Information
  33. 8.6.2 Medytox Business Overview
  34. 8.6.3 Medytox Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medytox Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  36. 8.6.5 Medytox Recent Developments
  37. 8.7 Ipsen
  38. 8.7.1 Ipsen Company Information
  39. 8.7.2 Ipsen Business Overview
  40. 8.7.3 Ipsen Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ipsen Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  42. 8.7.5 Ipsen Recent Developments
  43. 8.8 Hugel
  44. 8.8.1 Hugel Company Information
  45. 8.8.2 Hugel Business Overview
  46. 8.8.3 Hugel Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hugel Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  48. 8.8.5 Hugel Recent Developments
  49. 8.9 Galderma
  50. 8.9.1 Galderma Company Information
  51. 8.9.2 Galderma Business Overview
  52. 8.9.3 Galderma Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Galderma Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  54. 8.9.5 Galderma Recent Developments
  55. 8.10 Daewoong
  56. 8.10.1 Daewoong Company Information
  57. 8.10.2 Daewoong Business Overview
  58. 8.10.3 Daewoong Neurotoxin-based Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Daewoong Neurotoxin-based Injectable Anti-aging Product Product Portfolio
  60. 8.10.5 Daewoong Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurotoxin-based Injectable Anti-aging Product Value Chain Analysis
  2. 9.1.1 Neurotoxin-based Injectable Anti-aging Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurotoxin-based Injectable Anti-aging Product Production Mode & Process
  6. 9.2 Neurotoxin-based Injectable Anti-aging Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurotoxin-based Injectable Anti-aging Product Distributors
  9. 9.2.3 Neurotoxin-based Injectable Anti-aging Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst